Global Wound Closure Devices Pipeline Report 2022 – Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others – ResearchAndMarkets.com

Global Wound Closure Devices Pipeline Report 2022 – Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others – ResearchAndMarkets.com




Global Wound Closure Devices Pipeline Report 2022 – Featuring Abyrx, ACell, Acro Biomedical and Actamax Surgical Materials Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive information about the Wound Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Wound closure devices are used to close wounds that occur due to injuries or surgical procedures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Wound Closure Devices – Pipeline Products by Stage of Development

3.2 Wound Closure Devices – Pipeline Products by Segment

3.3 Wound Closure Devices – Pipeline Products by Territory

3.4 Wound Closure Devices – Pipeline Products by Regulatory Path

3.5 Wound Closure Devices – Pipeline Products by Estimated Approval Date

3.6 Wound Closure Devices – Ongoing Clinical Trials

4 Wound Closure Devices – Pipeline Products under Development by Companies

4.1 Wound Closure Devices Companies – Pipeline Products by Stage of Development

4.2 Wound Closure Devices – Pipeline Products by Stage of Development

5 Wound Closure Devices Companies and Product Overview

6 Wound Closure Devices – Recent Developments

7 Appendix

Companies Mentioned

  • 3-D Matrix Ltd
  • Abyrx, Inc.
  • ACell Inc
  • Acro Biomedical Co Ltd
  • Actamax Surgical Materials LLC
  • Adhesys Medical GmbH
  • Advanced Biotech Products Pvt Ltd
  • Advanced Medical Solutions Group plc
  • AFYX Therapeutics A/S
  • Alafair Biosciences Inc
  • Albert Ludwig University of Freiburg
  • Aleo BME Inc
  • Alumend LLC
  • Angiotech Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • APRUS Bio-Medical Innovations Pvt Ltd
  • ARC Medical Devices Inc
  • Arch Therapeutics Inc
  • Arizona State University
  • Artivion Inc
  • Aura Medsystems, Inc.
  • BaroStitch
  • Baxter Healthcare Corp
  • Baxter International Inc
  • Bayer AG
  • Bergen Medical Products Inc
  • Beth Israel Deaconess Medical Center
  • BioActive Polymers in Lund AB
  • BioDevek Inc
  • Biomedica Management Corp
  • Biom’Up SAS
  • BNC Korea Co Ltd
  • Borayer Biotechnology Co Ltd
  • Boston University
  • Calmare Therapeutics Inc
  • CardioCommand Inc
  • Cellphire Inc
  • Ceramicos Para Aplicacoes Medicas SA
  • Clemson University
  • Cohera Medical Inc
  • Columbia University
  • Covalent Medical, Inc. (Inactive)
  • Covalon Technologies Ltd
  • Covidien Ltd
  • CR Bard Inc
  • Cresilon Inc
  • Department of Biomedical Engineering Columbia University
  • DSM Biomedical BV
  • Duke University
  • Eidgenossische Materialprufungs- und Forschungsanstalt
  • Elastagen Pty Ltd
  • Emory University
  • Endomedix Incorporated
  • Entegrion Inc
  • Ethicon Endo-Surgery Inc
  • Ethicon US LLC
  • ETX Pharma Inc
  • FzioMed Inc
  • Gamma Diagnostics Inc
  • GATT Technologies BV
  • Genzyme Corp
  • Haemostatix Ltd
  • Hangzhou Kangji Medical Instrument Co Ltd
  • Hemostasis LLC
  • HLL Lifecare Ltd
  • HydroGlaze BV
  • HyperBranch Medical Technology Inc
  • Ichor Sciences LLC
  • Innocoll Technologies Ltd (Inactive)
  • Institute of Molecular Biology of Parana
  • InVivo Therapeutics Corp
  • IonMed Ltd.
  • Jiangxi Boenruier Biotechnology Co Ltd
  • Johns Hopkins University
  • Keratin Biosciences Inc
  • Kollodis BioSciences Inc
  • Kuros Biosciences AG
  • Kytogenics Pharmaceuticals Inc
  • Lap IQ Inc
  • Laser Tissue Welding, Inc.
  • Latch Medical Ltd
  • Leader Biomedical Europe BV
  • Lenvitz Medical Solutions Pvt Ltd
  • Life Care Medical Devices Ltd
  • Luna Innovations Inc
  • Magen OrthoMed Ltd
  • Massachusetts Institute of Technology
  • Maxigen Biotech Inc
  • Medcura Inc
  • Medisse BV (Inactive)
  • Meril Life Sciences Pvt Ltd
  • MLM Biologics Inc
  • N8 Medical LLC
  • Nanyang Technological University
  • National University of Ireland Galway
  • National University of Singapore
  • Northwestern University
  • Nurami Medical Ltd
  • OptMed, Inc.
  • PetVivo Holdings Inc
  • Pharming Group NV
  • Polyganics BV
  • PolyNovo Biomaterials Pty Ltd
  • Progress and Health Foundation
  • Protege Biomedical LLC
  • Protein Polymer Technologies Inc (Inactive)
  • Purdue University
  • Radiation Monitoring Devices Inc
  • Regenics AS
  • Resorba GmbH
  • Rice University
  • Rutgers The State University of New Jersey
  • Samyang Biopharmaceuticals Corp
  • Sanofi Biosurgery Inc
  • Sea Run Holdings Inc
  • Sealantis Ltd.
  • Seikagaku Corp
  • Seraffix Ltd
  • Shanghai Haohai Biological Technology Co Ltd
  • Sporogenics Pte Ltd
  • St Teresa Medical Inc
  • Stanford University
  • Starling Surgical
  • STB Lifesaving Technologies
  • Surgical Energetics LLC
  • Surgical Sealants, Inc.
  • Tectum
  • Teijin Pharma Ltd
  • Tetratherix Pty Ltd
  • Texas A&M University
  • The Medicines Co
  • TheraCell Inc
  • Therus Corporation
  • Thrombotargets Corp
  • Tissium SA
  • Toray Medical Co Ltd
  • Tribos LLC
  • Tricol Biomedical Inc
  • TYBR Health Inc
  • United Health Products, Inc.
  • University of Akron
  • University of Grenoble Alpes
  • University of Kansas
  • University of Minnesota
  • University of North Carolina at Chapel Hill
  • University of Pennsylvania
  • University of Toledo
  • Virginia Commonwealth University
  • WoundZipper Inc
  • Xcede Technologies Inc
  • Yale University
  • Yantai Zhenghai Biological Technology Co Ltd
  • Z-Medica LLC
  • ZSX Medical LLC

For more information about this report visit https://www.researchandmarkets.com/r/itkuom

Source: GlobalData

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900